Cisplatin-induced haemolytic uraemic syndrome associated with a novel intronic mutation of CD46 treated with eculizumab

A 2-year-old patient with a neuroblastoma developed haemolytic uraemic syndrome (HUS) following treatment with cisplatin and carboplatin. Following treatment with eculizumab, there was a substantial improvement in renal function with the recovery of the platelet count and the cessation of haemolysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Rodney D., Stanley, Louise K., Fowler, Darren J., Angus, Elizabeth M., Hardy, Steven A., Goodship, Timothy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888095/
https://www.ncbi.nlm.nih.gov/pubmed/24422172
http://dx.doi.org/10.1093/ckj/sft065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888095/
https://www.ncbi.nlm.nih.gov/pubmed/24422172
http://dx.doi.org/10.1093/ckj/sft065

Ejemplares similares